CompaniesByCap
RARE
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare

Ultragenyx Pharmaceutical Inc. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-466.0M-414.0M-475.0M-380.5M-338.7M-132.2M-345.4M-290.6M-253.8M-161.0M
Depreciation & Amort.35.0M36.0M26.0M18.2M13.2M12.3M8.5M19.5M5.8M3.4M
Investing Activities
Capital Expenditure6.0M7.0M44.0M116.1M73.1M43.9M24.8M4.1M2.8M10.2M
Free Cash Flow-472.0M-421.0M-519.0M-496.6M-411.8M-176.1M-370.2M-294.6M-256.6M-171.2M
Financing Activities
Dividends Paid
Stock Buybacks

Ultragenyx Pharmaceutical Inc. Cash Flow — FAQ

Ultragenyx Pharmaceutical Inc. (RARE) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RARE's cash flow history?

The chart and table above show Ultragenyx Pharmaceutical Inc.'s cash flow by year and by quarter, including the growth rate.